Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 1999

View Archived Issues

MUC1 mucin expression related to T-cell activation

Reticulose enhances efficacy of HAART cocktail in two case studies

Amrad to distribute PathoGenesis's inhalable CF treatment in Australia

Bayer to acquire OSI's diagnostics business

Patent licensed to Endorex/Elan joint venture covers mucosal delivery systems

Preliminary phase III results disappointing for Anogesic as anal fissure therapy

Gliatech soon to begin phase II Perceptin trials in ADHD

Abbott acquires anesthesia/analgesia products from Glaxo Wellcome

Abbott and Alza update merger proceedings

Pozen licenses migraine prophylactic from Roche

AxyS and Merck extend osteoporosis collaboration

Once-weekly Fosamax as effective as daily dosing

Xenova's IND for multidrug resistance modulator gets FDA approval

Novel antitumor agents for both leukemias and solid tumors discovered by Taiwanese scientists

Calcimimetics and calcilytics designed at NPS

Sanofi-Synthelabo pipeline includes compounds with neurotrophic/neuroprotective effects

Calcium channel blockers with piperidine structure synthesized at NeuroSearch

Abbott's new LHRH antagonists, pharmaceutical compositions and use

Korean investigators disclose new hepatoprotective agents

Methylenecyclopropane nucleoside analogues as effective agents for CMV infections

Eradication of H. pylori infection obtained with low doses of new cephem

Azimilide pharmacokinetics not significantly affected by severe renal impairment

Pharmacokinetics and pharmacodynamics of eniporide assessed over wide dose range

WHI-D12 is a potent and selective inhibitor of Bruton's tyrosine kinase

New acylfulvene analogues with clinical potential identified by MGI Pharma

Geldanamycin derivative with selective activity against breast cancer developed at Sloan-Kettering

Gender does not affect PK of Sch-58235: results presented at 1999 AAPS

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...